Quavonlimab
Product Specifications
CAS Number
2254059-25-9
Target
Others
Related Pathways
Others
Purity
0.969
Bioactivity
Quavonlimab (MK-1308) is a novel human monoclonal antibody designed to selectively target and block the immune checkpoint molecule cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), investigation of quavonlimab in combination with the anti-PD-1 therapy KEYTRUDA (pembrolizumab) has shown encouraging anti-tumor activity along with an acceptable safety profile, making it an interesting compound for the reasearches into advanced non-small cell lung cancer (NSCLC) .
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx328922-01 50 µg
Eukaryotic Translation Initiation Factor 4E Binding Protein 1 (EIF4EBP1) Antibody
Ask
View Details 
abx328922-02 100 µg
Eukaryotic Translation Initiation Factor 4E Binding Protein 1 (EIF4EBP1) Antibody
Ask
View Details 